

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.21246000 |
| 2 | desmosome organization (GO:0002934) | 3.20544343 |
| 3 | locomotory exploration behavior (GO:0035641) | 3.11584398 |
| 4 | layer formation in cerebral cortex (GO:0021819) | 2.94154909 |
| 5 | cell communication by electrical coupling (GO:0010644) | 2.93295109 |
| 6 | synaptic vesicle maturation (GO:0016188) | 2.89395224 |
| 7 | cell communication involved in cardiac conduction (GO:0086065) | 2.83828968 |
| 8 | negative regulation of fatty acid transport (GO:2000192) | 2.83636906 |
| 9 | hemidesmosome assembly (GO:0031581) | 2.80042589 |
| 10 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.77453312 |
| 11 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.75408561 |
| 12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.74270254 |
| 13 | interkinetic nuclear migration (GO:0022027) | 2.73611185 |
| 14 | plasma membrane repair (GO:0001778) | 2.68488432 |
| 15 | fatty acid transmembrane transport (GO:1902001) | 2.67200134 |
| 16 | carnitine shuttle (GO:0006853) | 2.66806550 |
| 17 | sodium ion export (GO:0071436) | 2.62939141 |
| 18 | activation of protein kinase A activity (GO:0034199) | 2.60516275 |
| 19 | endocardial cushion development (GO:0003197) | 2.59910846 |
| 20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.57368191 |
| 21 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.56128014 |
| 22 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.53497222 |
| 23 | embryonic foregut morphogenesis (GO:0048617) | 2.53208051 |
| 24 | regulation of hippo signaling (GO:0035330) | 2.52971128 |
| 25 | iron ion import (GO:0097286) | 2.51445613 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 2.50681207 |
| 27 | lymphangiogenesis (GO:0001946) | 2.49566029 |
| 28 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.48143198 |
| 29 | establishment of nucleus localization (GO:0040023) | 2.46917812 |
| 30 | lysine metabolic process (GO:0006553) | 2.44848744 |
| 31 | lysine catabolic process (GO:0006554) | 2.44848744 |
| 32 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.44056440 |
| 33 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.43853275 |
| 34 | cell-substrate junction assembly (GO:0007044) | 2.43363609 |
| 35 | positive regulation of fatty acid oxidation (GO:0046321) | 2.43179138 |
| 36 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.42167985 |
| 37 | cell adhesion mediated by integrin (GO:0033627) | 2.40585824 |
| 38 | vocalization behavior (GO:0071625) | 2.40525072 |
| 39 | import into cell (GO:0098657) | 2.39962342 |
| 40 | nucleus localization (GO:0051647) | 2.39439970 |
| 41 | glutamate secretion (GO:0014047) | 2.38256113 |
| 42 | dendrite morphogenesis (GO:0048813) | 2.35945644 |
| 43 | myelination in peripheral nervous system (GO:0022011) | 2.32859102 |
| 44 | peripheral nervous system axon ensheathment (GO:0032292) | 2.32859102 |
| 45 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.32820829 |
| 46 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.31495363 |
| 47 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.30382951 |
| 48 | cerebellar granule cell differentiation (GO:0021707) | 2.29311218 |
| 49 | gap junction assembly (GO:0016264) | 2.27669601 |
| 50 | proline transport (GO:0015824) | 2.27466421 |
| 51 | neuron remodeling (GO:0016322) | 2.26503745 |
| 52 | negative regulation of protein localization to cell surface (GO:2000009) | 2.26257445 |
| 53 | cellular potassium ion homeostasis (GO:0030007) | 2.26061244 |
| 54 | alanine transport (GO:0032328) | 2.25284726 |
| 55 | regulation of ARF protein signal transduction (GO:0032012) | 2.24062785 |
| 56 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.23682001 |
| 57 | positive regulation of muscle hypertrophy (GO:0014742) | 2.23682001 |
| 58 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.23000729 |
| 59 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.21964472 |
| 60 | regulation of synapse structural plasticity (GO:0051823) | 2.21215540 |
| 61 | phospholipid translocation (GO:0045332) | 2.20748064 |
| 62 | lipid translocation (GO:0034204) | 2.20748064 |
| 63 | protein targeting to Golgi (GO:0000042) | 2.19687603 |
| 64 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.19298900 |
| 65 | pericardium development (GO:0060039) | 2.18792301 |
| 66 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.18772805 |
| 67 | L-phenylalanine catabolic process (GO:0006559) | 2.18772805 |
| 68 | negative regulation of catenin import into nucleus (GO:0035414) | 2.18767544 |
| 69 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.18651798 |
| 70 | potassium ion import (GO:0010107) | 2.16267160 |
| 71 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.16243789 |
| 72 | protein localization to endosome (GO:0036010) | 2.16154613 |
| 73 | regulation of fatty acid oxidation (GO:0046320) | 2.15488821 |
| 74 | glutamate metabolic process (GO:0006536) | 2.15325275 |
| 75 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.14425740 |
| 76 | relaxation of cardiac muscle (GO:0055119) | 2.13763277 |
| 77 | chemical homeostasis within a tissue (GO:0048875) | 2.13740751 |
| 78 | dendritic spine morphogenesis (GO:0060997) | 2.13355288 |
| 79 | myotube differentiation (GO:0014902) | 2.13334885 |
| 80 | cardiac myofibril assembly (GO:0055003) | 2.12825608 |
| 81 | macroautophagy (GO:0016236) | 2.12259508 |
| 82 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.11788483 |
| 83 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.11388877 |
| 84 | regulation of cholesterol homeostasis (GO:2000188) | 2.11357589 |
| 85 | establishment of protein localization to Golgi (GO:0072600) | 2.09682141 |
| 86 | apical protein localization (GO:0045176) | 2.08161342 |
| 87 | vesicle transport along microtubule (GO:0047496) | 2.06704630 |
| 88 | carnitine transmembrane transport (GO:1902603) | 2.06303536 |
| 89 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.05147256 |
| 90 | surfactant homeostasis (GO:0043129) | 2.05086093 |
| 91 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.04947356 |
| 92 | gamma-aminobutyric acid transport (GO:0015812) | 2.04830814 |
| 93 | myoblast fusion (GO:0007520) | 2.04575122 |
| 94 | positive regulation of glycogen metabolic process (GO:0070875) | 2.03621064 |
| 95 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.03403062 |
| 96 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.02858870 |
| 97 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.02809751 |
| 98 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.02574704 |
| 99 | cellular sodium ion homeostasis (GO:0006883) | 2.02553327 |
| 100 | artery development (GO:0060840) | 2.02325862 |
| 101 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.01895015 |
| 102 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.01870727 |
| 103 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.01598164 |
| 104 | mesodermal cell differentiation (GO:0048333) | 2.01166698 |
| 105 | smooth muscle tissue development (GO:0048745) | 2.00736439 |
| 106 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.00430469 |
| 107 | 2-oxoglutarate metabolic process (GO:0006103) | 2.00022968 |
| 108 | amino-acid betaine transport (GO:0015838) | 1.99948443 |
| 109 | carnitine transport (GO:0015879) | 1.99948443 |
| 110 | hippo signaling (GO:0035329) | 1.99191517 |
| 111 | regulation of p38MAPK cascade (GO:1900744) | 1.99004230 |
| 112 | cell-substrate adherens junction assembly (GO:0007045) | 1.98672111 |
| 113 | focal adhesion assembly (GO:0048041) | 1.98672111 |
| 114 | neurotransmitter secretion (GO:0007269) | 1.98581089 |
| 115 | positive regulation of lipid catabolic process (GO:0050996) | 1.98431435 |
| 116 | camera-type eye morphogenesis (GO:0048593) | 1.98380601 |
| 117 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 1.98321589 |
| 118 | L-phenylalanine metabolic process (GO:0006558) | 1.98321589 |
| 119 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 1.98218342 |
| 120 | exploration behavior (GO:0035640) | 1.97561391 |
| 121 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 1.97070458 |
| 122 | adherens junction assembly (GO:0034333) | 1.96984534 |
| 123 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 1.96693260 |
| 124 | regulation of axon guidance (GO:1902667) | 1.96665591 |
| 125 | regulation of membrane repolarization (GO:0060306) | 1.95706674 |
| 126 | vascular endothelial growth factor signaling pathway (GO:0038084) | 1.95641736 |
| 127 | neuromuscular process controlling balance (GO:0050885) | 1.95526093 |
| 128 | neurotransmitter-gated ion channel clustering (GO:0072578) | 1.95421294 |
| 129 | negative regulation of hormone biosynthetic process (GO:0032353) | 1.95018510 |
| 130 | SMAD protein complex assembly (GO:0007183) | 1.94902207 |
| 131 | complement activation, alternative pathway (GO:0006957) | 1.93269121 |
| 132 | stress fiber assembly (GO:0043149) | 1.92810568 |
| 133 | regulation of transforming growth factor beta2 production (GO:0032909) | 1.92545823 |
| 134 | glomerular visceral epithelial cell development (GO:0072015) | 1.91876982 |
| 135 | positive regulation of synapse maturation (GO:0090129) | 1.91844978 |
| 136 | neuromuscular junction development (GO:0007528) | 1.91614658 |
| 137 | regulation of clathrin-mediated endocytosis (GO:2000369) | 1.91571733 |
| 138 | negative regulation of keratinocyte proliferation (GO:0010839) | 1.91549216 |
| 139 | glycine transport (GO:0015816) | 1.91376438 |
| 140 | skin morphogenesis (GO:0043589) | 1.90920554 |
| 141 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 1.90894440 |
| 142 | phospholipid homeostasis (GO:0055091) | 1.90616435 |
| 143 | cardiac conduction (GO:0061337) | 1.90524617 |
| 144 | aspartate family amino acid catabolic process (GO:0009068) | 1.90515739 |
| 145 | embryonic camera-type eye morphogenesis (GO:0048596) | 1.89844429 |
| 146 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 1.89697447 |
| 147 | cerebellar Purkinje cell differentiation (GO:0021702) | 1.89042219 |
| 148 | synaptic vesicle exocytosis (GO:0016079) | 1.89011378 |
| 149 | sodium ion homeostasis (GO:0055078) | 1.87974458 |
| 150 | positive regulation of glucose import (GO:0046326) | 1.87662815 |
| 151 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 1.87536142 |
| 152 | regulation of protein activation cascade (GO:2000257) | 1.86238992 |
| 153 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 1.85202387 |
| 154 | regulation of protein polyubiquitination (GO:1902914) | 1.85187670 |
| 155 | morphogenesis of an epithelial sheet (GO:0002011) | 1.85075958 |
| 156 | cardiac muscle cell action potential (GO:0086001) | 1.83979991 |
| 157 | myofibril assembly (GO:0030239) | 1.83795223 |
| 158 | nerve growth factor signaling pathway (GO:0038180) | 1.83500413 |
| 159 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 1.83408087 |
| 160 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 1.83249554 |
| 161 | sequestering of extracellular ligand from receptor (GO:0035581) | 1.83169710 |
| 162 | clathrin coat assembly (GO:0048268) | 1.82514129 |
| 163 | protein targeting to plasma membrane (GO:0072661) | 1.82217766 |
| 164 | membrane assembly (GO:0071709) | 1.82207817 |
| 165 | asymmetric protein localization (GO:0008105) | 1.81741995 |
| 166 | regulation of muscle adaptation (GO:0043502) | 1.80724544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.48157031 |
| 2 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.34497557 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.02657479 |
| 4 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.00021279 |
| 5 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.89745599 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.88917394 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.87512926 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.85238816 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.84048612 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.84048612 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.82840248 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.82319890 |
| 13 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.79198064 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.74736291 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.74209008 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.71866367 |
| 17 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.67037591 |
| 18 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.66152266 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.62712473 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.61401982 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.61309726 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59763358 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.57790574 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.57664957 |
| 25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.54739802 |
| 26 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.51462598 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.49739884 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48112453 |
| 29 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.46096676 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44211310 |
| 31 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.42698239 |
| 32 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.40219167 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.39565902 |
| 34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.38045425 |
| 35 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.37217467 |
| 36 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.37205237 |
| 37 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35733810 |
| 38 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.34838181 |
| 39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.34826105 |
| 40 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.34207880 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33058436 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33048207 |
| 43 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.31978156 |
| 44 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31948651 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.31731836 |
| 46 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.30963739 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.30810924 |
| 48 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.30438810 |
| 49 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.30102238 |
| 50 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.28177842 |
| 51 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.26644367 |
| 52 | KDM2B_26808549_Chip-Seq_K562_Human | 1.25347036 |
| 53 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.24496367 |
| 54 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.22688143 |
| 55 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21515697 |
| 56 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18808848 |
| 57 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.18521238 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.18290372 |
| 59 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18069602 |
| 60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17202080 |
| 61 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.16787629 |
| 62 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16640958 |
| 63 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.16139959 |
| 64 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.15152294 |
| 65 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14747231 |
| 66 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14371323 |
| 67 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.13297169 |
| 68 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13036076 |
| 69 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.12086606 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10925140 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10925140 |
| 72 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10504879 |
| 73 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.10309679 |
| 74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09639568 |
| 75 | AR_19668381_ChIP-Seq_PC3_Human | 1.08519779 |
| 76 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.08333510 |
| 77 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08041166 |
| 78 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07949693 |
| 79 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.07576475 |
| 80 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.07498663 |
| 81 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07136755 |
| 82 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06711302 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06107121 |
| 84 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.05967200 |
| 85 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05107519 |
| 86 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04649765 |
| 87 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04448509 |
| 88 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.03889972 |
| 89 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.03889972 |
| 90 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.03553839 |
| 91 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02691285 |
| 92 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.02514309 |
| 93 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.01968673 |
| 94 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.01880153 |
| 95 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.01686723 |
| 96 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01518535 |
| 97 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.01488512 |
| 98 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01256006 |
| 99 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99838533 |
| 100 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99789211 |
| 101 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.99324739 |
| 102 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99030490 |
| 103 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98885646 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98643007 |
| 105 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 0.98600855 |
| 106 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97679459 |
| 107 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96735005 |
| 108 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.96175785 |
| 109 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96127644 |
| 110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95693399 |
| 111 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95348023 |
| 112 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95299726 |
| 113 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.94124190 |
| 114 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.93445648 |
| 115 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92366683 |
| 116 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92133400 |
| 117 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.90695927 |
| 118 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.89006316 |
| 119 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87883174 |
| 120 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.87176391 |
| 121 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86687686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.17292383 |
| 2 | MP0009780_abnormal_chondrocyte_physiolo | 2.88572570 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 2.68840065 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 2.56033654 |
| 5 | MP0005409_darkened_coat_color | 2.48886384 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.48158874 |
| 7 | MP0005360_urolithiasis | 2.43644716 |
| 8 | MP0005365_abnormal_bile_salt | 2.27713306 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.22159871 |
| 10 | MP0003252_abnormal_bile_duct | 2.17571065 |
| 11 | MP0004130_abnormal_muscle_cell | 2.12688952 |
| 12 | MP0000751_myopathy | 2.12611870 |
| 13 | MP0010368_abnormal_lymphatic_system | 2.04773655 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.03457375 |
| 15 | MP0004272_abnormal_basement_membrane | 2.00463565 |
| 16 | MP0004270_analgesia | 1.95162133 |
| 17 | MP0004084_abnormal_cardiac_muscle | 1.93816843 |
| 18 | MP0003950_abnormal_plasma_membrane | 1.85363314 |
| 19 | MP0002909_abnormal_adrenal_gland | 1.77712442 |
| 20 | MP0005503_abnormal_tendon_morphology | 1.72198765 |
| 21 | MP0010352_gastrointestinal_tract_polyps | 1.72171949 |
| 22 | MP0003635_abnormal_synaptic_transmissio | 1.68146685 |
| 23 | MP0004215_abnormal_myocardial_fiber | 1.68032024 |
| 24 | MP0005187_abnormal_penis_morphology | 1.66520387 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.60093167 |
| 26 | MP0000013_abnormal_adipose_tissue | 1.51794230 |
| 27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.51731617 |
| 28 | MP0003045_fibrosis | 1.51609072 |
| 29 | MP0005167_abnormal_blood-brain_barrier | 1.49343083 |
| 30 | MP0000383_abnormal_hair_follicle | 1.46989477 |
| 31 | MP0003879_abnormal_hair_cell | 1.45911601 |
| 32 | MP0004036_abnormal_muscle_relaxation | 1.45053353 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.44659499 |
| 34 | MP0005623_abnormal_meninges_morphology | 1.44406857 |
| 35 | MP0004885_abnormal_endolymph | 1.43777233 |
| 36 | MP0010678_abnormal_skin_adnexa | 1.42818801 |
| 37 | MP0008961_abnormal_basal_metabolism | 1.42702236 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.40754133 |
| 39 | MP0003091_abnormal_cell_migration | 1.39421207 |
| 40 | MP0003283_abnormal_digestive_organ | 1.36407484 |
| 41 | MP0004858_abnormal_nervous_system | 1.35052883 |
| 42 | MP0005275_abnormal_skin_tensile | 1.32661114 |
| 43 | MP0001348_abnormal_lacrimal_gland | 1.32173094 |
| 44 | MP0006138_congestive_heart_failure | 1.29282455 |
| 45 | MP0005670_abnormal_white_adipose | 1.28093958 |
| 46 | MP0003941_abnormal_skin_development | 1.27693661 |
| 47 | MP0002063_abnormal_learning/memory/cond | 1.27002885 |
| 48 | MP0004043_abnormal_pH_regulation | 1.26655613 |
| 49 | MP0004085_abnormal_heartbeat | 1.24897538 |
| 50 | MP0004087_abnormal_muscle_fiber | 1.24220995 |
| 51 | MP0005248_abnormal_Harderian_gland | 1.21336844 |
| 52 | MP0002009_preneoplasia | 1.20072357 |
| 53 | MP0005330_cardiomyopathy | 1.20033708 |
| 54 | MP0008775_abnormal_heart_ventricle | 1.19187395 |
| 55 | MP0005375_adipose_tissue_phenotype | 1.17441627 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.16541922 |
| 57 | MP0002972_abnormal_cardiac_muscle | 1.14965758 |
| 58 | MP0008438_abnormal_cutaneous_collagen | 1.13339719 |
| 59 | MP0001879_abnormal_lymphatic_vessel | 1.11791222 |
| 60 | MP0002118_abnormal_lipid_homeostasis | 1.11466945 |
| 61 | MP0003195_calcinosis | 1.10876878 |
| 62 | * MP0005620_abnormal_muscle_contractility | 1.10779159 |
| 63 | MP0000566_synostosis | 1.09636859 |
| 64 | MP0005332_abnormal_amino_acid | 1.09337174 |
| 65 | MP0000003_abnormal_adipose_tissue | 1.09023860 |
| 66 | MP0001299_abnormal_eye_distance/ | 1.09000289 |
| 67 | MP0003300_gastrointestinal_ulcer | 1.08507679 |
| 68 | MP0009745_abnormal_behavioral_response | 1.08167167 |
| 69 | MP0002822_catalepsy | 1.07854835 |
| 70 | MP0003329_amyloid_beta_deposits | 1.07443127 |
| 71 | MP0004484_altered_response_of | 1.07150167 |
| 72 | MP0005257_abnormal_intraocular_pressure | 1.03841639 |
| 73 | MP0003137_abnormal_impulse_conducting | 1.02952930 |
| 74 | MP0002896_abnormal_bone_mineralization | 1.02608897 |
| 75 | MP0004147_increased_porphyrin_level | 1.02517232 |
| 76 | MP0002234_abnormal_pharynx_morphology | 1.02061295 |
| 77 | MP0003890_abnormal_embryonic-extraembry | 1.01713567 |
| 78 | MP0009384_cardiac_valve_regurgitation | 1.01504869 |
| 79 | MP0001177_atelectasis | 1.01027656 |
| 80 | MP0003690_abnormal_glial_cell | 1.00284910 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 0.99804049 |
| 82 | MP0009046_muscle_twitch | 0.99404026 |
| 83 | MP0000733_abnormal_muscle_development | 0.96484283 |
| 84 | MP0005083_abnormal_biliary_tract | 0.95584342 |
| 85 | MP0000462_abnormal_digestive_system | 0.95576677 |
| 86 | MP0010630_abnormal_cardiac_muscle | 0.94758406 |
| 87 | MP0004145_abnormal_muscle_electrophysio | 0.94503595 |
| 88 | MP0000534_abnormal_ureter_morphology | 0.94094343 |
| 89 | MP0002734_abnormal_mechanical_nocicepti | 0.92760111 |
| 90 | MP0003942_abnormal_urinary_system | 0.92712427 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.92237201 |
| 92 | MP0005385_cardiovascular_system_phenoty | 0.92148001 |
| 93 | MP0001544_abnormal_cardiovascular_syste | 0.92148001 |
| 94 | MP0002064_seizures | 0.91944458 |
| 95 | MP0002108_abnormal_muscle_morphology | 0.91931401 |
| 96 | MP0002168_other_aberrant_phenotype | 0.90617346 |
| 97 | MP0000767_abnormal_smooth_muscle | 0.90251119 |
| 98 | MP0005023_abnormal_wound_healing | 0.90095172 |
| 99 | MP0001486_abnormal_startle_reflex | 0.89393992 |
| 100 | MP0000579_abnormal_nail_morphology | 0.89353979 |
| 101 | MP0000747_muscle_weakness | 0.89113926 |
| 102 | MP0003633_abnormal_nervous_system | 0.88397477 |
| 103 | MP0002090_abnormal_vision | 0.87692986 |
| 104 | MP0002269_muscular_atrophy | 0.87006351 |
| 105 | MP0000427_abnormal_hair_cycle | 0.86964670 |
| 106 | MP0004233_abnormal_muscle_weight | 0.86849747 |
| 107 | MP0000428_abnormal_craniofacial_morphol | 0.84721668 |
| 108 | MP0004134_abnormal_chest_morphology | 0.83881572 |
| 109 | MP0003632_abnormal_nervous_system | 0.83504817 |
| 110 | MP0000749_muscle_degeneration | 0.83261972 |
| 111 | MP0002295_abnormal_pulmonary_circulatio | 0.83202927 |
| 112 | MP0000762_abnormal_tongue_morphology | 0.82050291 |
| 113 | MP0001958_emphysema | 0.81332523 |
| 114 | MP0005535_abnormal_body_temperature | 0.80571391 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.79991710 |
| 116 | MP0003646_muscle_fatigue | 0.79935815 |
| 117 | MP0002572_abnormal_emotion/affect_behav | 0.79136461 |
| 118 | MP0003868_abnormal_feces_composition | 0.78777364 |
| 119 | MP0001666_abnormal_nutrient_absorption | 0.78133841 |
| 120 | MP0004782_abnormal_surfactant_physiolog | 0.77949325 |
| 121 | MP0009053_abnormal_anal_canal | 0.76965257 |
| 122 | MP0000778_abnormal_nervous_system | 0.74697304 |
| 123 | MP0002735_abnormal_chemical_nociception | 0.74563222 |
| 124 | MP0002971_abnormal_brown_adipose | 0.74204039 |
| 125 | MP0003385_abnormal_body_wall | 0.73645026 |
| 126 | MP0003935_abnormal_craniofacial_develop | 0.73148718 |
| 127 | MP0001849_ear_inflammation | 0.72451785 |
| 128 | MP0002128_abnormal_blood_circulation | 0.71803192 |
| 129 | MP0003566_abnormal_cell_adhesion | 0.71688662 |
| 130 | MP0000537_abnormal_urethra_morphology | 0.71304690 |
| 131 | MP0001756_abnormal_urination | 0.71159427 |
| 132 | MP0001440_abnormal_grooming_behavior | 0.70807147 |
| 133 | MP0008569_lethality_at_weaning | 0.70649125 |
| 134 | MP0003279_aneurysm | 0.70298940 |
| 135 | MP0002925_abnormal_cardiovascular_devel | 0.69203065 |
| 136 | MP0010386_abnormal_urinary_bladder | 0.68830494 |
| 137 | MP0005386_behavior/neurological_phenoty | 0.68717682 |
| 138 | MP0004924_abnormal_behavior | 0.68717682 |
| 139 | MP0003937_abnormal_limbs/digits/tail_de | 0.67951032 |
| 140 | MP0001661_extended_life_span | 0.67191068 |
| 141 | MP0003631_nervous_system_phenotype | 0.66879985 |
| 142 | MP0002184_abnormal_innervation | 0.65796834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 3.27114353 |
| 2 | Arterial tortuosity (HP:0005116) | 2.99319211 |
| 3 | Sudden death (HP:0001699) | 2.93800944 |
| 4 | Protrusio acetabuli (HP:0003179) | 2.89579110 |
| 5 | Vascular tortuosity (HP:0004948) | 2.79638187 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 2.77919175 |
| 7 | Hyporeflexia of lower limbs (HP:0002600) | 2.69447874 |
| 8 | Action tremor (HP:0002345) | 2.65046053 |
| 9 | Broad metatarsal (HP:0001783) | 2.62441285 |
| 10 | Ketoacidosis (HP:0001993) | 2.55120687 |
| 11 | Lymphangioma (HP:0100764) | 2.53597047 |
| 12 | Bundle branch block (HP:0011710) | 2.48489831 |
| 13 | Hypoglycemic coma (HP:0001325) | 2.43114631 |
| 14 | Aortic dissection (HP:0002647) | 2.38327338 |
| 15 | Papillary thyroid carcinoma (HP:0002895) | 2.35456902 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 2.29244224 |
| 17 | Xanthomatosis (HP:0000991) | 2.26659671 |
| 18 | Difficulty running (HP:0009046) | 2.26171460 |
| 19 | Ketosis (HP:0001946) | 2.21790819 |
| 20 | Ventricular fibrillation (HP:0001663) | 2.20776632 |
| 21 | Shallow orbits (HP:0000586) | 2.20756228 |
| 22 | Macroorchidism (HP:0000053) | 2.20234246 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 2.20204919 |
| 24 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.19300504 |
| 25 | Osteolytic defects of the hand bones (HP:0009699) | 2.19300504 |
| 26 | Cerebral aneurysm (HP:0004944) | 2.19024218 |
| 27 | Turricephaly (HP:0000262) | 2.19017788 |
| 28 | Dysmetric saccades (HP:0000641) | 2.17647911 |
| 29 | Atrioventricular block (HP:0001678) | 2.17331420 |
| 30 | Premature rupture of membranes (HP:0001788) | 2.17156276 |
| 31 | Hyperglycemia (HP:0003074) | 2.17002774 |
| 32 | Myokymia (HP:0002411) | 2.16849196 |
| 33 | Hyperventilation (HP:0002883) | 2.13379100 |
| 34 | Syncope (HP:0001279) | 2.12824212 |
| 35 | Cardiovascular calcification (HP:0011915) | 2.10901634 |
| 36 | Focal seizures (HP:0007359) | 2.10512736 |
| 37 | Prolonged QT interval (HP:0001657) | 2.10296597 |
| 38 | Epidermoid cyst (HP:0200040) | 2.09269243 |
| 39 | Atrial fibrillation (HP:0005110) | 2.08244787 |
| 40 | Bronchomalacia (HP:0002780) | 2.07090444 |
| 41 | Mitral stenosis (HP:0001718) | 2.06874421 |
| 42 | Focal segmental glomerulosclerosis (HP:0000097) | 2.06847071 |
| 43 | Exercise-induced myalgia (HP:0003738) | 2.06460382 |
| 44 | Complement deficiency (HP:0004431) | 2.06022918 |
| 45 | Hypoglycemic seizures (HP:0002173) | 2.04677627 |
| 46 | Focal motor seizures (HP:0011153) | 2.03928160 |
| 47 | Aneurysm (HP:0002617) | 2.01780872 |
| 48 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99573075 |
| 49 | Primary atrial arrhythmia (HP:0001692) | 1.97298849 |
| 50 | Overgrowth (HP:0001548) | 1.95815280 |
| 51 | Heart block (HP:0012722) | 1.95228855 |
| 52 | Skin nodule (HP:0200036) | 1.94867935 |
| 53 | Increased connective tissue (HP:0009025) | 1.94813925 |
| 54 | Enlarged penis (HP:0000040) | 1.94180752 |
| 55 | Wormian bones (HP:0002645) | 1.92976856 |
| 56 | Atrophic scars (HP:0001075) | 1.92036468 |
| 57 | Impaired social interactions (HP:0000735) | 1.91872564 |
| 58 | Abnormal social behavior (HP:0012433) | 1.91872564 |
| 59 | Vertebral arch anomaly (HP:0008438) | 1.91851165 |
| 60 | Subacute progressive viral hepatitis (HP:0006572) | 1.90708868 |
| 61 | Abnormal atrioventricular conduction (HP:0005150) | 1.89464292 |
| 62 | Ventricular arrhythmia (HP:0004308) | 1.86615817 |
| 63 | Bladder diverticulum (HP:0000015) | 1.86049993 |
| 64 | Hyperlipoproteinemia (HP:0010980) | 1.84957516 |
| 65 | Muscle fiber splitting (HP:0003555) | 1.84932978 |
| 66 | Vascular calcification (HP:0004934) | 1.84159993 |
| 67 | Flat acetabular roof (HP:0003180) | 1.83938063 |
| 68 | Glomerulosclerosis (HP:0000096) | 1.83384381 |
| 69 | Heterotopia (HP:0002282) | 1.82728160 |
| 70 | Ankyloglossia (HP:0010296) | 1.82483043 |
| 71 | Renovascular hypertension (HP:0100817) | 1.81689561 |
| 72 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.80406726 |
| 73 | Aplasia of the phalanges of the hand (HP:0009802) | 1.80406726 |
| 74 | Aplasia involving bones of the extremities (HP:0009825) | 1.80406726 |
| 75 | Hepatoblastoma (HP:0002884) | 1.78867077 |
| 76 | Supraventricular arrhythmia (HP:0005115) | 1.78302071 |
| 77 | Limited hip movement (HP:0008800) | 1.78155109 |
| 78 | Insidious onset (HP:0003587) | 1.77882873 |
| 79 | Termporal pattern (HP:0011008) | 1.77882873 |
| 80 | Increased circulating renin level (HP:0000848) | 1.77815546 |
| 81 | Obstructive sleep apnea (HP:0002870) | 1.77523449 |
| 82 | Polycythemia (HP:0001901) | 1.76985412 |
| 83 | Hamartoma of the eye (HP:0010568) | 1.76952681 |
| 84 | Cubitus valgus (HP:0002967) | 1.76181580 |
| 85 | Gout (HP:0001997) | 1.73976822 |
| 86 | Intention tremor (HP:0002080) | 1.73959701 |
| 87 | Fair hair (HP:0002286) | 1.73869454 |
| 88 | Supraventricular tachycardia (HP:0004755) | 1.73656786 |
| 89 | Abnormality of the ischium (HP:0003174) | 1.72862814 |
| 90 | Hypoplasia of the iris (HP:0007676) | 1.72255915 |
| 91 | Neonatal short-limb short stature (HP:0008921) | 1.72225920 |
| 92 | Ventricular tachycardia (HP:0004756) | 1.70798532 |
| 93 | Visceral angiomatosis (HP:0100761) | 1.70506699 |
| 94 | Increased variability in muscle fiber diameter (HP:0003557) | 1.69358520 |
| 95 | Esophageal varix (HP:0002040) | 1.68609964 |
| 96 | Long toe (HP:0010511) | 1.68374596 |
| 97 | Abnormality of the calf musculature (HP:0001430) | 1.67902084 |
| 98 | Postural instability (HP:0002172) | 1.67305332 |
| 99 | Torticollis (HP:0000473) | 1.67249021 |
| 100 | Abnormality of the lower motor neuron (HP:0002366) | 1.66219669 |
| 101 | Hyperactive renin-angiotensin system (HP:0000841) | 1.65078627 |
| 102 | Hemiplegia (HP:0002301) | 1.64940626 |
| 103 | Dysdiadochokinesis (HP:0002075) | 1.64899045 |
| 104 | Genetic anticipation (HP:0003743) | 1.64336978 |
| 105 | Visual hallucinations (HP:0002367) | 1.64232734 |
| 106 | Poor eye contact (HP:0000817) | 1.64149355 |
| 107 | Germ cell neoplasia (HP:0100728) | 1.64003762 |
| 108 | Myoglobinuria (HP:0002913) | 1.63877283 |
| 109 | Hyperglycinuria (HP:0003108) | 1.63721986 |
| 110 | Hemangiomatosis (HP:0007461) | 1.63308755 |
| 111 | Abnormality of the common coagulation pathway (HP:0010990) | 1.63104960 |
| 112 | Short nail (HP:0001799) | 1.62491111 |
| 113 | Generalized hypopigmentation of hair (HP:0011358) | 1.61887199 |
| 114 | Hyperkalemia (HP:0002153) | 1.61588958 |
| 115 | Hepatocellular carcinoma (HP:0001402) | 1.61358875 |
| 116 | Hyperacusis (HP:0010780) | 1.60957738 |
| 117 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.60351566 |
| 118 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.60250414 |
| 119 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.60210098 |
| 120 | Blue irides (HP:0000635) | 1.60174545 |
| 121 | Fragile skin (HP:0001030) | 1.60129894 |
| 122 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.59922676 |
| 123 | Mitral valve prolapse (HP:0001634) | 1.59296657 |
| 124 | Depression (HP:0000716) | 1.58683744 |
| 125 | Buphthalmos (HP:0000557) | 1.58193394 |
| 126 | Hyperammonemia (HP:0001987) | 1.58156450 |
| 127 | Type 1 muscle fiber predominance (HP:0003803) | 1.58115316 |
| 128 | Advanced eruption of teeth (HP:0006288) | 1.57798113 |
| 129 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.57192669 |
| 130 | Broad face (HP:0000283) | 1.56590698 |
| 131 | Striae distensae (HP:0001065) | 1.56032855 |
| 132 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.55863104 |
| 133 | Hematochezia (HP:0002573) | 1.55549733 |
| 134 | Cerebral inclusion bodies (HP:0100314) | 1.55217301 |
| 135 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.55018369 |
| 136 | Resting tremor (HP:0002322) | 1.54750737 |
| 137 | Short chin (HP:0000331) | 1.54445491 |
| 138 | Aortic aneurysm (HP:0004942) | 1.54303024 |
| 139 | Lower limb amyotrophy (HP:0007210) | 1.54206235 |
| 140 | Wide anterior fontanel (HP:0000260) | 1.54112054 |
| 141 | Status epilepticus (HP:0002133) | 1.53989207 |
| 142 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.53782124 |
| 143 | Pheochromocytoma (HP:0002666) | 1.53616794 |
| 144 | Exercise-induced muscle cramps (HP:0003710) | 1.53089994 |
| 145 | Coronal craniosynostosis (HP:0004440) | 1.52279334 |
| 146 | Asymmetry of the thorax (HP:0001555) | 1.49880932 |
| 147 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.49858284 |
| 148 | Abnormality of potassium homeostasis (HP:0011042) | 1.49714368 |
| 149 | Abnormality of the nasal septum (HP:0000419) | 1.49152231 |
| 150 | Spinal cord compression (HP:0002176) | 1.48982165 |
| 151 | Spinal rigidity (HP:0003306) | 1.48699547 |
| 152 | Persistence of primary teeth (HP:0006335) | 1.46818943 |
| 153 | Cutaneous finger syndactyly (HP:0010554) | 1.46545006 |
| 154 | Hypoplastic labia majora (HP:0000059) | 1.46035741 |
| 155 | Insomnia (HP:0100785) | 1.45987105 |
| 156 | Bradycardia (HP:0001662) | 1.45748081 |
| 157 | Relative macrocephaly (HP:0004482) | 1.45687091 |
| 158 | Abnormality of chloride homeostasis (HP:0011422) | 1.45526081 |
| 159 | Tibial bowing (HP:0002982) | 1.44819471 |
| 160 | Decreased motor nerve conduction velocity (HP:0003431) | 1.42415558 |
| 161 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.41558805 |
| 162 | Hyperaldosteronism (HP:0000859) | 1.41477510 |
| 163 | Ulnar bowing (HP:0003031) | 1.41153403 |
| 164 | Protruding tongue (HP:0010808) | 1.40845375 |
| 165 | Tracheomalacia (HP:0002779) | 1.40553574 |
| 166 | Open mouth (HP:0000194) | 1.40534944 |
| 167 | Soft skin (HP:0000977) | 1.40169477 |
| 168 | Febrile seizures (HP:0002373) | 1.39844208 |
| 169 | Metabolic alkalosis (HP:0200114) | 1.38036604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 2.71578876 |
| 2 | CASK | 2.66982572 |
| 3 | TRIB3 | 2.56865145 |
| 4 | RIPK1 | 2.37120373 |
| 5 | EEF2K | 2.23188889 |
| 6 | NTRK3 | 2.12355407 |
| 7 | PRKD3 | 2.08132354 |
| 8 | INSRR | 1.96451574 |
| 9 | SIK1 | 1.96091314 |
| 10 | MAP3K9 | 1.89999900 |
| 11 | EPHA4 | 1.84455708 |
| 12 | MARK1 | 1.80312894 |
| 13 | PDGFRA | 1.77396198 |
| 14 | CAMK1G | 1.77357588 |
| 15 | LMTK2 | 1.76338599 |
| 16 | TRPM7 | 1.68889137 |
| 17 | DAPK2 | 1.61678048 |
| 18 | PHKG1 | 1.60834065 |
| 19 | PHKG2 | 1.60834065 |
| 20 | MAP3K2 | 1.57361104 |
| 21 | FRK | 1.56753213 |
| 22 | LATS2 | 1.55210040 |
| 23 | MAP3K4 | 1.53672446 |
| 24 | PAK6 | 1.51506259 |
| 25 | CDK12 | 1.51343288 |
| 26 | CAMK1D | 1.51148769 |
| 27 | FER | 1.50528949 |
| 28 | TIE1 | 1.47861014 |
| 29 | FGFR2 | 1.47137003 |
| 30 | STK38 | 1.45126978 |
| 31 | PKN2 | 1.44084220 |
| 32 | EPHA2 | 1.43942868 |
| 33 | NTRK1 | 1.43225851 |
| 34 | MAP2K4 | 1.41988430 |
| 35 | DMPK | 1.36749513 |
| 36 | MYLK | 1.35647362 |
| 37 | TTN | 1.35001359 |
| 38 | CAMKK1 | 1.34167643 |
| 39 | PAK3 | 1.33469562 |
| 40 | WNK4 | 1.32466462 |
| 41 | NEK9 | 1.31196496 |
| 42 | KSR2 | 1.29118219 |
| 43 | SGK3 | 1.27693328 |
| 44 | PRKCH | 1.26176445 |
| 45 | EPHB2 | 1.26112284 |
| 46 | PTK6 | 1.24357168 |
| 47 | RET | 1.24237733 |
| 48 | STK38L | 1.20894282 |
| 49 | MINK1 | 1.10676584 |
| 50 | DDR2 | 1.10120709 |
| 51 | SGK2 | 1.05623684 |
| 52 | NTRK2 | 1.00397511 |
| 53 | CDC42BPA | 0.98727894 |
| 54 | TYRO3 | 0.97800697 |
| 55 | MAP3K7 | 0.96716981 |
| 56 | MST1R | 0.96469063 |
| 57 | WNK1 | 0.95862350 |
| 58 | SGK223 | 0.95687225 |
| 59 | SGK494 | 0.95687225 |
| 60 | ACVR1B | 0.94048382 |
| 61 | TAOK1 | 0.92366553 |
| 62 | PTK2 | 0.90612812 |
| 63 | PAK2 | 0.88549022 |
| 64 | MAP3K6 | 0.88482906 |
| 65 | MELK | 0.86686406 |
| 66 | FGFR4 | 0.86423355 |
| 67 | PRKD1 | 0.83468008 |
| 68 | FGFR3 | 0.81933658 |
| 69 | PIK3CA | 0.81371630 |
| 70 | PDGFRB | 0.80996456 |
| 71 | CDK5 | 0.80576720 |
| 72 | KSR1 | 0.80525998 |
| 73 | PRKAA1 | 0.78309004 |
| 74 | MARK2 | 0.77440973 |
| 75 | PDPK1 | 0.74813322 |
| 76 | ROCK1 | 0.73072553 |
| 77 | ERBB2 | 0.71746953 |
| 78 | STK11 | 0.71399213 |
| 79 | PNCK | 0.71107313 |
| 80 | PDK3 | 0.68762667 |
| 81 | PDK4 | 0.68762667 |
| 82 | BMX | 0.68686494 |
| 83 | SGK1 | 0.65812742 |
| 84 | MAP3K1 | 0.63615955 |
| 85 | MAPKAPK3 | 0.63590784 |
| 86 | ERN1 | 0.62742572 |
| 87 | MET | 0.62678908 |
| 88 | STK3 | 0.62602098 |
| 89 | ICK | 0.62353469 |
| 90 | PRKAA2 | 0.61067744 |
| 91 | STK39 | 0.60331563 |
| 92 | RPS6KA2 | 0.60086794 |
| 93 | SCYL2 | 0.58986392 |
| 94 | FGFR1 | 0.58804032 |
| 95 | MTOR | 0.58747841 |
| 96 | JAK1 | 0.58498026 |
| 97 | MAP2K1 | 0.58408458 |
| 98 | CAMK1 | 0.57118509 |
| 99 | CAMK4 | 0.57080971 |
| 100 | WNK3 | 0.57008896 |
| 101 | OBSCN | 0.56726429 |
| 102 | PTK2B | 0.56072498 |
| 103 | PINK1 | 0.55714119 |
| 104 | AKT3 | 0.55021124 |
| 105 | ERBB4 | 0.54229423 |
| 106 | PDK1 | 0.54027878 |
| 107 | OXSR1 | 0.51742700 |
| 108 | EPHA3 | 0.51337953 |
| 109 | PRKCE | 0.50817631 |
| 110 | PRKCZ | 0.49984222 |
| 111 | RPS6KA3 | 0.49822971 |
| 112 | CAMK2B | 0.49353625 |
| 113 | CAMK2A | 0.49241540 |
| 114 | MAP3K12 | 0.48945183 |
| 115 | MAPK10 | 0.48542087 |
| 116 | TGFBR2 | 0.48394228 |
| 117 | EPHB1 | 0.48356694 |
| 118 | NEK6 | 0.47946125 |
| 119 | CAMKK2 | 0.47897483 |
| 120 | GSK3A | 0.45168743 |
| 121 | PRKD2 | 0.37999166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.54177490 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.95579925 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.80052803 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.71384763 |
| 5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.71227451 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.67717071 |
| 7 | Bile secretion_Homo sapiens_hsa04976 | 1.45789476 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.44964660 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.41985885 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.37978211 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.36263848 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 1.28232997 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.28009798 |
| 14 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.27942784 |
| 15 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.27542844 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.27092981 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.23085506 |
| 18 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.20646458 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.19942622 |
| 20 | Circadian entrainment_Homo sapiens_hsa04713 | 1.19904189 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19156642 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.18778639 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.18129127 |
| 24 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.17770599 |
| 25 | Circadian rhythm_Homo sapiens_hsa04710 | 1.15877542 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.14103271 |
| 27 | GABAergic synapse_Homo sapiens_hsa04727 | 1.13885888 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13856630 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.13233396 |
| 30 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.11317168 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.11052563 |
| 32 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.09219029 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.07362333 |
| 34 | Renin secretion_Homo sapiens_hsa04924 | 1.07330806 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.07298647 |
| 36 | Long-term potentiation_Homo sapiens_hsa04720 | 1.07184495 |
| 37 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.05520773 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.02820442 |
| 39 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.01050942 |
| 40 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.99578857 |
| 41 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.98664361 |
| 42 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.97810727 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97537932 |
| 44 | Olfactory transduction_Homo sapiens_hsa04740 | 0.96938740 |
| 45 | Insulin resistance_Homo sapiens_hsa04931 | 0.96683602 |
| 46 | Lysine degradation_Homo sapiens_hsa00310 | 0.94651781 |
| 47 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.94506658 |
| 48 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.91704314 |
| 49 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.90828381 |
| 50 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.90822366 |
| 51 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.90401973 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89636327 |
| 53 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.89114301 |
| 54 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.88366985 |
| 55 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.87767913 |
| 56 | Morphine addiction_Homo sapiens_hsa05032 | 0.87711091 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87512782 |
| 58 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.86447077 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85302915 |
| 60 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.84117822 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84112479 |
| 62 | Focal adhesion_Homo sapiens_hsa04510 | 0.82645310 |
| 63 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.82613770 |
| 64 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.82521787 |
| 65 | Nicotine addiction_Homo sapiens_hsa05033 | 0.82338643 |
| 66 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.81790396 |
| 67 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.81557000 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81164706 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79488255 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79335290 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79329637 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.78779255 |
| 73 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.77909896 |
| 74 | Melanoma_Homo sapiens_hsa05218 | 0.77391607 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76974533 |
| 76 | Gap junction_Homo sapiens_hsa04540 | 0.76682761 |
| 77 | Cocaine addiction_Homo sapiens_hsa05030 | 0.76096590 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75842303 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75001791 |
| 80 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74955308 |
| 81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.74392752 |
| 82 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.73730806 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.73229083 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.72106883 |
| 85 | Melanogenesis_Homo sapiens_hsa04916 | 0.71844562 |
| 86 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71811088 |
| 87 | Adherens junction_Homo sapiens_hsa04520 | 0.71494172 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.71297742 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70747397 |
| 90 | * Axon guidance_Homo sapiens_hsa04360 | 0.70318600 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69877858 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.69611295 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69466014 |
| 94 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69433187 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68861098 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68847087 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.67852810 |
| 98 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67496453 |
| 99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67462210 |
| 100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66911549 |
| 101 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.66796280 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66654214 |
| 103 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.65142852 |
| 104 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.63617654 |
| 105 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63518796 |
| 106 | Prostate cancer_Homo sapiens_hsa05215 | 0.62748676 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62496703 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62415508 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.62328986 |
| 110 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61959271 |
| 111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60823099 |
| 112 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.60602024 |
| 113 | Taste transduction_Homo sapiens_hsa04742 | 0.60064759 |
| 114 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.59946822 |
| 115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59934774 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58625631 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57260457 |
| 118 | Tight junction_Homo sapiens_hsa04530 | 0.55974096 |
| 119 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55612021 |
| 120 | Long-term depression_Homo sapiens_hsa04730 | 0.54597872 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54021719 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51903624 |
| 123 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51524433 |
| 124 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51487667 |
| 125 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51133055 |
| 126 | Peroxisome_Homo sapiens_hsa04146 | 0.50323203 |
| 127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49479287 |
| 128 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48102633 |
| 129 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45664254 |

